Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

IMPORTANCE: The optimal treatment approach to patients with acute myeloid leukemia (AML) who relapse after an allogeneic hematopoietic cell transplant (allo-HCT) remains elusive. No randomized clinical trial comparing survival outcomes of a second allo-HCT (allo-HCT2) vs donor lymphocyte infusion (D...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Oncol
Glavni autori: Kharfan-Dabaja, Mohamed A., Labopin, Myriam, Polge, Emmanuelle, Nishihori, Taiga, Bazarbachi, Ali, Finke, Jürgen, Stadler, Michael, Ehninger, Gerhard, Lioure, Bruno, Schaap, Nicolaas, Afanasyev, Boris, Yeshurun, Moshe, Isaksson, Cecilia, Maertens, Johan, Chalandon, Yves, Schmid, Christoph, Nagler, Arnon, Mohty, Mohamad
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2018
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143013/
https://ncbi.nlm.nih.gov/pubmed/30003233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.2091
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items